Feature | May 06, 2014

Siemens Announces FDA Clearance of Artis one Angiography System

May 6, 2014 — Siemens Healthcare announced the U.S. Food and Drug Administration (FDA) has cleared the Artis one angiography system, optimized for broad clinical utilization. The Artis one is designed for routine interventions, including revascularizations of peripheral vessel occlusions, functional tests of dialysis shunts in patients with kidney failure, diagnostic or minimally invasive angiographic treatment of narrowed coronary arteries, and pacemaker implantations.


Flexible With Low Space Requirement

Despite being floor-mounted, the Artis one features a positioning flexibility similar to ceiling-mounted systems and occupies just 269 square feet, compared to the standard 484 square feet required by ceiling-mounted systems. The system features several axes that can move independently of each other, enabling physicians and hospital staff to easily position the system where needed, regardless of where they stand. It accommodates full head-to-toe coverage of patients up to 6 feet, 10 inches without the need for patient repositioning. The system also allows free access to the patient's head, enabling optimal care during the procedure.

Tactile buttons on the Artis one’s tableside console can be manipulated easily even under the sterile covering. The on-screen, menu-guided user interface allows the physician to navigate directly using the heads-up display. All information regarding the procedure remains directly in front of the operator. And the 30-inch display size delivers images up to 90 percent larger than conventional 19-inch monitors.


Premium Cardio Applications, Powerful X-ray Tube

Artis one’s Clearstent Live application for interventional cardiology procedures — previously available only with Artis Q and Artis Q.zen — freezes motion in the region of the stent, allowing the physician to mask out movement of the beating heart and place the stent in precisely the correct position. The Artis one also offers new tools for cardiac imaging, including HeartSweep, which uses dual-axis rotational angiography to image the entire heart in a single, smooth C-arm movement instead of multiple acquisitions from different projections. This single-sweep movement has the potential to speed up procedures and save contrast agents. By utilizing 20 percent less energy than the Artis zee floor system, the Artis one also helps reduce operational costs.

The Artis one angiography system is available in multiple configurations.

For more information: www.usa.siemens.com/healthcare

Related Content

Technology | Radial Access| February 17, 2017
Medtronic plc announced that its coronary portfolio will now include the DxTerity Diagnostic Angiography Catheter line...
Sponsored Content | Videos | Inventory Management| February 17, 2017
The supplies you use in your cath lab are complex and very valuable.
Mercator MedSystems, DANCE trial data, ISET, LINC, Bullfrog Micro-Infusion Device
News | Peripheral Arterial Disease (PAD)| February 15, 2017
Mercator MedSystems announced that the national co-principal investigators of the company’s DANCE trial each presented...
Cardinal Health survey, hospital staff, supply chain management, quality of care
News | Inventory Management| February 15, 2017
Better hospital supply chain management leads to better quality of care and supports patient safety, according to a new...
University of Alabama at Birmingham, Amplatzer PFO Occluder, first implementation
News | Structural Heart Occluders| February 15, 2017
Doctors at the University of Alabama at Birmingham have implemented the first U.S. Food and Drug Administration (FDA)-...
Biotronik, PRO-Kinetic Energy cobalt chromium coronary stent system, FDA approval
Technology | Stents Bare Metal| February 15, 2017
The PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from Biotronik has gained U.S. Food and Drug...
heart team, hybird OR, structural heart team

The heart team approach was first used on a large scale in the CoreValve and Sapien TAVR trials and helped lead to excellent outcomes in high-risk patients.

Feature | Hybrid OR| February 15, 2017 | Dave Fornell
In the current era of healthcare reform and the push toward evidence-based medicine to both lower costs and improve p
HeartFlow FFRct Analysis, NICE guidance, U.K., United Kingdom, guidelines, stable chest pain
News | CT Angiography (CTA)| February 14, 2017
The National Institute for Health and Care Excellence (NICE) in the United Kingdom recently issued guidance for use of...
News | Hypertension| February 13, 2017
Vascular Dynamics Inc. (VDI) announced that the U.S. Food and Drug Administration (FDA) has approved the company’s...
 Intra-atrial shunt device (IASD) to lower left atrial pressure by creating a small left atrial to right atrial shunt.  Abraham said these devices are in early stage development with small studies to show proof of concept and demonstrate safety.

The Corvia Intra-atrial shunt device (IASD) lowers left atrial pressure by creating a small left atrial to right atrial shunt. Preliminary clinical studies have shown promise for these types of devices to improve HFpEF patient outcomes.

Feature | Heart Failure| February 10, 2017 | Dave Fornell
In the past few years there have been a number of device therapies developed to treat heart failure (HF).
Overlay Init